H&Q Healthcare Investors

H&Q Healthcare Investors provides early and later stage funding and is a Massachusetts-based healthcare fund.

Number of Investments

Number of Lead Investments

10

1

H&Q Healthcare Investors has made 10 investments. Their most recent investment was on Apr 3, 2014, when Neurovance raised $6.30M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 3, 2014 Neurovance	Series A	$6.30M	Biotechnology	—
Mar 1, 2013 CardioKinetix	Series E	$23M	Biotechnology	—
Jan 8, 2013 Labcyte	Series D	$5.30M	Alternative Medicine	—
Oct 18, 2012 Neurovance	Series Unknown	$7M	Biotechnology	—
Oct 5, 2011 Puma Biotechnology	Post-IPO Equity	$55M	Biotechnology	—

H&Q Healthcare Investors has had 6 exits. H&Q Healthcare Investors most notable exits include Labcyte , Neurovance

Date	Company Name	Exit Type	Industry
Jan 30, 2019	Labcyte	M&A	Alternative Medicine	Detail
Mar 2, 2017	Neurovance	M&A	Biotechnology	Detail
May 11, 2015	PHT Corporation	M&A	Clinical Trials	Detail
Apr 20, 2012	Puma Biotechnology	IPO	Biotechnology	Detail
Mar 19, 2008	CardioNet	IPO	Biotechnology	Detail